Sino Biopharmaceutical Ltd
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 1177-HK would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2004) — listing | $361,392 11.1× | $531,165 11.0× |
| Year 6 (2009) | $97,751 3.8× | $144,690 3.8× |
| Year 11 (2014) | $25,761 1.4× | $38,268 1.4× |
| Year 16 (2019) | $11,545 1.1× | $17,188 1.1× |
| Year 21 (2024) | $4,313 1.2× | $6,484 1.2× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 1177
For illustration only — not investment advice. Past performance is not indicative of future results.